review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Michael Blaut | Q54344505 |
P2093 | author name string | Anni Woting | |
P2860 | cites work | Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis | Q22253259 |
Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41 | Q24304955 | ||
The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids | Q24337476 | ||
Obesity alters gut microbial ecology | Q24531503 | ||
Diversity of the human intestinal microbial flora | Q24544241 | ||
A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism | Q24548304 | ||
Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation | Q24553023 | ||
Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice | Q24568168 | ||
An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice | Q24601321 | ||
Metagenomic analysis of the human distal gut microbiome | Q24633486 | ||
A core gut microbiome in obese and lean twins | Q24649648 | ||
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice | Q24676006 | ||
The L-Cell in Nutritional Sensing and the Regulation of Appetite | Q26799942 | ||
Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity | Q26828547 | ||
Specificity of Polysaccharide Use in Intestinal Bacteroides Species Determines Diet-Induced Microbiota Alterations | Q27663126 | ||
An obesity-associated gut microbiome with increased capacity for energy harvest | Q27860515 | ||
Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes | Q42833865 | ||
Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. | Q42931889 | ||
Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women | Q43481704 | ||
Higher level of faecal SCFA in women correlates with metabolic syndrome risk factors | Q44105668 | ||
The currently used commercial DNA-extraction methods give different results of clostridial and actinobacterial populations derived from human fecal samples | Q44133394 | ||
Butyrate activates the cAMP-protein kinase A-cAMP response element-binding protein signaling pathway in Caco-2 cells | Q44971084 | ||
Energy intake is associated with endotoxemia in apparently healthy men. | Q45769895 | ||
Gut microbiota and energy balance: role in obesity | Q46797438 | ||
Molecular characterisation of the faecal microbiota in patients with type II diabetes | Q46864209 | ||
Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits | Q46947624 | ||
Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice. | Q47446607 | ||
Effects of long-term soluble vs. insoluble dietary fiber intake on high-fat diet-induced obesity in C57BL/6J mice | Q48003269 | ||
Nutrient control of energy homeostasis via gut-brain neural circuits | Q48476223 | ||
Absence of intestinal microbiota does not protect mice from diet-induced obesity. | Q51401205 | ||
Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. | Q51498948 | ||
Early differences in fecal microbiota composition in children may predict overweight. | Q53219254 | ||
The metabolism of methylsulfinylalkyl- and methylthioalkyl-glucosinolates by a selection of human gut bacteria. | Q54301456 | ||
Formation of Phenolic and Indolic Compounds by Anaerobic Bacteria in the Human Large Intestine | Q54415546 | ||
Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure | Q59385209 | ||
A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation | Q60998567 | ||
Dissimilatory amino Acid metabolism in human colonic bacteria | Q80057162 | ||
Intestinal microbiota and obesity | Q37976362 | ||
The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity | Q38319091 | ||
Bacterial species involved in the conversion of dietary flavonoids in the human gut. | Q38768604 | ||
Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial | Q39122523 | ||
Characterization of four outer membrane proteins involved in binding starch to the cell surface of Bacteroides thetaiotaomicron | Q39585705 | ||
Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. | Q39830081 | ||
The germfree animal in nutritional studies | Q40255137 | ||
Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor | Q40638952 | ||
Factors affecting fermentation reactions in the large bowel | Q40777218 | ||
Inflammation and metabolic disorders | Q27860923 | ||
Microbial ecology: human gut microbes associated with obesity | Q27861004 | ||
The gut microbiota as an environmental factor that regulates fat storage | Q28131676 | ||
Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene | Q28138952 | ||
Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue | Q28272732 | ||
Increased oral detection, but decreased intestinal signaling for fats in mice lacking gut microbiota | Q28480933 | ||
A hybrid two-component system protein of a prominent human gut symbiont couples glycan sensing in vivo to carbohydrate metabolism | Q28492127 | ||
Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2 | Q28592795 | ||
Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review | Q28757173 | ||
Diet rapidly and reproducibly alters the human gut microbiome | Q29547454 | ||
Metabolic endotoxemia initiates obesity and insulin resistance | Q29547720 | ||
The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice | Q29614457 | ||
Molecular analysis of commensal host-microbial relationships in the intestine | Q29614776 | ||
Gut microbiota from twins discordant for obesity modulate metabolism in mice | Q29614796 | ||
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity | Q29615051 | ||
Microbiota and SCFA in lean and overweight healthy subjects | Q29615812 | ||
Richness of human gut microbiome correlates with metabolic markers | Q29617365 | ||
Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome | Q29617424 | ||
Glycan foraging in vivo by an intestine-adapted bacterial symbiont | Q29617848 | ||
Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4) | Q33711961 | ||
Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. | Q33992194 | ||
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. | Q34006689 | ||
Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers | Q34024108 | ||
The endocannabinoid system links gut microbiota to adipogenesis | Q34078880 | ||
Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals | Q34277472 | ||
Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging | Q34320513 | ||
Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist | Q34326973 | ||
Clostridium ramosum promotes high-fat diet-induced obesity in gnotobiotic mouse models. | Q34334686 | ||
Gut metagenome in European women with normal, impaired and diabetic glucose control | Q34347521 | ||
Dietary fiber and body weight | Q34407291 | ||
Bile salt hydrolase activity in probiotics. | Q34432358 | ||
Bile acids and the gut microbiome | Q34432618 | ||
High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway | Q34455345 | ||
Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology | Q34481919 | ||
Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity | Q34622388 | ||
Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. | Q34629736 | ||
Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity | Q34651315 | ||
An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice | Q34785134 | ||
Human colonic microbiota associated with diet, obesity and weight loss | Q34823807 | ||
Diet dominates host genotype in shaping the murine gut microbiota | Q34978394 | ||
Effect of Lactobacillus plantarum Strain K21 on High-Fat Diet-Fed Obese Mice | Q35158545 | ||
Diet-induced obesity causes metabolic impairment independent of alterations in gut barrier integrity | Q35560150 | ||
Dietary Polyphenols Promote Growth of the Gut Bacterium Akkermansia muciniphila and Attenuate High-Fat Diet-Induced Metabolic Syndrome | Q35595578 | ||
Effect of regulatory protein levels on utilization of starch by Bacteroides thetaiotaomicron | Q35618026 | ||
Changes in dominant groups of the gut microbiota do not explain cereal-fiber induced improvement of whole-body insulin sensitivity | Q35690051 | ||
Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial | Q35718362 | ||
Dietary fibre and incidence of type 2 diabetes in eight European countries: the EPIC-InterAct Study and a meta-analysis of prospective studies | Q35757071 | ||
Glucosinolates Are Mainly Absorbed Intact in Germfree and Human Microbiota-Associated Mice | Q35771957 | ||
Predicting a human gut microbiota's response to diet in gnotobiotic mice | Q35829905 | ||
Gut microbiota-derived lipopolysaccharide uptake and trafficking to adipose tissue: implications for inflammation and obesity. | Q35880172 | ||
Characterization of the Gut Microbial Community of Obese Patients Following a Weight-Loss Intervention Using Whole Metagenome Shotgun Sequencing | Q35937626 | ||
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice | Q36087089 | ||
Prioritization of a plant polysaccharide over a mucus carbohydrate is enforced by a Bacteroides hybrid two-component system. | Q36115702 | ||
Unique Organization of Extracellular Amylases into Amylosomes in the Resistant Starch-Utilizing Human Colonic Firmicutes Bacterium Ruminococcus bromii | Q36177525 | ||
Modulatory effects of sCD14 and LBP on LPS-host cell interactions | Q36263729 | ||
Microbial degradation of complex carbohydrates in the gut | Q36295226 | ||
Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults | Q36374810 | ||
Microbiota regulate intestinal absorption and metabolism of fatty acids in the zebrafish | Q36454308 | ||
The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract | Q36483117 | ||
Fructokinase, Fructans, Intestinal Permeability, and Metabolic Syndrome: An Equine Connection? | Q36622734 | ||
Probiotics: properties, examples, and specific applications. | Q36629073 | ||
Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41 | Q36942662 | ||
The role of sodium-coupled glucose co-transporter 3 in the satiety effect of portal glucose sensing. | Q37133457 | ||
Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. | Q37277544 | ||
Alleviation of high fat diet-induced obesity by oligofructose in gnotobiotic mice is independent of presence of Bifidobacterium longum | Q37308573 | ||
Effect of plasma triglyceride metabolism on lipid storage in adipose tissue: studies using genetically engineered mouse models | Q37377010 | ||
High-fat diet determines the composition of the murine gut microbiome independently of obesity | Q37404989 | ||
Modulation of plasma TG lipolysis by Angiopoietin-like proteins and GPIHBP1. | Q37670368 | ||
Evidence for greater production of colonic short-chain fatty acids in overweight than lean humans. | Q37676116 | ||
New insights into the molecular mechanism of intestinal fatty acid absorption | Q37718704 | ||
P275 | copyright license | Creative Commons Attribution | Q6905323 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | type 2 diabetes | Q3025883 |
intestine | Q9639 | ||
bacteria | Q10876 | ||
dyslipidemia | Q66291209 | ||
adiposity | Q71129164 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 202 | |
P577 | publication date | 2016-04-06 | |
P1433 | published in | Nutrients | Q7070485 |
P1476 | title | The Intestinal Microbiota in Metabolic Disease | |
P478 | volume | 8 |
Q90609548 | "Photobiomics": Can Light, Including Photobiomodulation, Alter the Microbiome? |
Q91639851 | Acupuncture Regulating Gut Microbiota in Abdominal Obese Rats Induced by High-Fat Diet |
Q93008463 | Additional Effect of Dietary Fiber in Patients with Type 2 Diabetes Mellitus Using Metformin and Sulfonylurea: An Open-Label, Pilot Trial |
Q41836455 | Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial |
Q46285672 | An extract from the Atlantic brown algae Saccorhiza polyschides counteracts diet-induced obesity in mice via a gut related multi-factorial mechanisms. |
Q55307054 | An overview on the interplay between nutraceuticals and gut microbiota. |
Q33918713 | Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis? |
Q33852050 | Are the Gut Bacteria Telling Us to Eat or Not to Eat? Reviewing the Role of Gut Microbiota in the Etiology, Disease Progression and Treatment of Eating Disorders |
Q45849451 | Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota. |
Q90555954 | Bi-directional drug-microbiome interactions of anti-diabetics |
Q47119292 | Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice. |
Q42115138 | Branched short-chain fatty acids modulate glucose and lipid metabolism in primary adipocytes. |
Q89534092 | Cholesterol-Lowering Effects of Lactobacillus Species |
Q41932327 | Control of Clostridium difficile Infection by Defined Microbial Communities. |
Q64091576 | Crosstalk between gut microbiota and antidiabetic drug action |
Q42379046 | Dietary Components and Metabolic Dysfunction: Translating Preclinical Studies into Clinical Practice |
Q92816263 | Dietary Fiber in Bilberry Ameliorates Pre-Obesity Events in Rats by Regulating Lipid Depot, Cecal Short-Chain Fatty Acid Formation and Microbiota Composition |
Q57805697 | Dietary fibers inhibit obesity in mice, but host responses in the cecum and liver appear unrelated to fiber-specific changes in cecal bacterial taxonomic composition |
Q51193316 | Dual function of Lactobacillus kefiri DH5 in preventing high-fat-diet-induced obesity: direct reduction of cholesterol and upregulation of PPAR-α in adipose tissue. |
Q89697823 | Early Programming of Adult Systemic Essential Hypertension |
Q46295791 | Effects of Antidiabetic Drugs on Gut Microbiota Composition |
Q64945369 | Effects of Bifidobacterium breve B-3 on body fat reductions in pre-obese adults: a randomized, double-blind, placebo-controlled trial. |
Q64279320 | Endocrine organs of cardiovascular diseases: Gut microbiota |
Q37660757 | Enterotype May Drive the Dietary-Associated Cardiometabolic Risk Factors |
Q64936598 | Faecal Microbiota Are Related to Insulin Sensitivity and Secretion in Overweight or Obese Adults. |
Q49587798 | Fiber-Mediated Nourishment of Gut Microbiota Protects against Diet-Induced Obesity by Restoring IL-22-Mediated Colonic Health |
Q41770716 | Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease |
Q52679038 | Gastrointestinal Transit Time, Glucose Homeostasis and Metabolic Health: Modulation by Dietary Fibers. |
Q103835852 | Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome |
Q33880087 | Gut microbiome diversity and high-fibre intake are related to lower long-term weight gain |
Q98726635 | Gut microbiota and diabetes: From correlation to causality and mechanism |
Q46879758 | Human Gut Microbiota Associated with Obesity in Chinese Children and Adolescents |
Q40145966 | Human monocytes downregulate innate response receptors following exposure to the microbial metabolite n-butyrate. |
Q64077102 | Implementing Dietary Modifications and Assessing Nutritional Adequacy of Diets for Inflammatory Bowel Disease |
Q90208116 | Induction Effects of Bacteroides fragilis Derived Outer Membrane Vesicles on Toll Like Receptor 2, Toll Like Receptor 4 Genes Expression and Cytokines Concentration in Human Intestinal Epithelial Cells |
Q55028032 | Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice. |
Q33839116 | Microbiota, Inflammation and Colorectal Cancer |
Q36055503 | Molecular Properties of Guar Gum and Pectin Modify Cecal Bile Acids, Microbiota, and Plasma Lipopolysaccharide-Binding Protein in Rats |
Q60047629 | Obesity: A New Adverse Effect of Antibiotics? |
Q48350209 | Pepsin egg white hydrolysate modulates gut microbiota in Zucker obese rats. |
Q38945964 | Positive effects of resistant starch supplementation on bowel function in healthy adults: a systematic review and meta-analysis of randomized controlled trials. |
Q47645890 | Probiotics, prebiotics, synbiotics and insulin sensitivity |
Q37713517 | Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation. |
Q49733575 | Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation |
Q38951451 | Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour |
Q38780926 | Roles of the gut in the metabolic syndrome: an overview |
Q48328173 | Starch Structure Influences Its Digestibility: A Review |
Q38781599 | Structure of protein emulsion in food impacts intestinal microbiota, caecal luminal content composition and distal intestine characteristics in rats. |
Q53187979 | The 9th Conference on Metal Toxicity and Carcinogenesis: The conference overview. |
Q92922235 | The Effects of Gelatinized Wheat Starch and High Salt Diet on Gut Microbiota and Metabolic Disorder |
Q92881956 | The effects of antibiotics and melatonin on hepato-intestinal inflammation and gut microbial dysbiosis induced by a short-term high-fat diet consumption in rats |
Q36161048 | The gut microbiota and gastrointestinal surgery |
Q89560976 | Time of Feeding Alters Obesity-Associated Parameters and Gut Bacterial Communities, but Not Fungal Populations, in C57BL/6 Male Mice |
Search more.